Readystate Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$896K Hold
31,400
– – 0.03% 355
2026
Q2
$756K Buy
31,400
+400
+1% +$10.5K 0.03% 484
2026
Q1
$870K Buy
+31,000
New +$825K 0.04% 259
2025
Q2
– Sell
-75,700
Closed -$1.92M – 866
2025
Q1
$1.92M Sell
75,700
-16,600
-18% -$434K 0.06% 328
2024
Q4
$2.45M Sell
92,300
-407,000
-82% -$11M 0.08% 268
2024
Q3
$14.4M Buy
499,300
+475,500
+1,998% +$13.9M 0.27% 125
2024
Q2
$666K Sell
23,800
-614,600
-96% -$16.9M 0.02% 433
2024
Q1
$17.7M Buy
638,400
+632,100
+10,033% +$17.5M 0.25% 64
2023
Q4
$181K Buy
+6,300
New +$190K 0.01% 537
2023
Q2
– Sell
-7,600
Closed -$310K – 388
2023
Q1
$310K Buy
+7,600
New +$328K 0.03% 244

Other funds holding PFE

Readystate Asset Management's PFE Position: Q3 2026 in Review

Readystate Asset Management sold out of Pfizer (PFE) in Q3 2026, closing a stake of 9,927 shares — an estimated $264K sold.

Readystate Asset Management first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $1.04M in Q4 2024. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Readystate Asset Management reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • Readystate Asset Management sold 9,927 Pfizer shares in Q3 2026, an estimated $264K.
  • Readystate Asset Management first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
  • Readystate Asset Management's Pfizer position peaked at $1.04M in Q4 2024.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Readystate Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.